RADIATION-ASSOCIATED CUTANEOUS BREAST ANGIOSARCOMA – 12 YEARS ANALYSIS OF A RADIATION ONCOLOGY DEPARTMENT

• Autor(a) principal: Roda, Domingos
• Data de Publicação: 2014
• Outros Autores: Melo, Gilberto, Figueiredo, Paulo
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: https://doi.org/10.29021/spdv.72.3.276
• topic: Breast neoplasms/radiotherapy; Hemangiosarcoma; Neoplasms; Radiation-induced; Skin neoplasms; Neoplasias da mama/radioterapia; Angiossarcoma; Neoplasias da pele; Neoplasias induzidas por radiação

Introduction: The radiation induced (RI) cutaneous angiosarcoma (CAS) in the context of the treatment of breast cancer is a rare but extremely aggressive tumor.Aim: The aim of this study was to review and present the clinical cases of RI CAS of a Radiotherapy (RT) service of, by analyzing the clinical in the last 12 years.Material and Methods: We retrospectively analyzed the clinical cases of primary atypical vascular lesions (AVL), primary CAS, RI AVL and RI CAS of the breast or chest wall (region previously submitted to mastectomy), diagnosed in our institution between 01.01.2000 e 31.12.2012.Results: We found a total of 14 patients: 2 (14 %) presented primary AVL; 2 (14%) secondary RI AVL, 5 (36%) primary CAS and 5 (36%) secondary RI CAS. The mean age at diagnosis of RI CAS was 62 years (x-y), the mean time after RT was 11.6 years (x-y) and the treatment of secondary cancer was wide excision in 80% of the cases. There were 3 deaths, none of which related to the radiation-induced injury.Discussion and Conclusion: These data are similar to other published series regarding the rarity of the breast RI CAS, age at diagnosis and the average time interval between the RT and the onset of secondary cancer. Differences regarding recurrence, metastasis and prognosis were found. The results highlight the importance of updated data concerning side effects of the treatments applied.